-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Share
Listen to the news

Gainers

  • Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million.
  • GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to $3.99. The market value of their outstanding shares is at $1.6 million.
  • Surrozen (NASDAQ:SRZN) stock increased by 34.62% to $21.76. The company's market cap stands at $189.9 million.
  • Pomdoctor (NASDAQ:POM) stock rose 17.48% to $0.94. The company's market cap stands at $7.4 million.
  • Lite Strategy (NASDAQ:LITS) stock rose 11.86% to $1.32. The market value of their outstanding shares is at $40.1 million.
  • Greenland Mines (NASDAQ:GRML) shares rose 11.52% to $12.48. The market value of their outstanding shares is at $35.5 million.

Losers

  • Artelo Biosciences (NASDAQ:ARTL) stock fell 30.1% to $5.11 during Thursday's pre-market session. The company's market cap stands at $4.0 million.
  • Silexion Therapeutics (NASDAQ:SLXN) shares fell 19.29% to $0.25. The company's market cap stands at $1.7 million.
  • Healthcare Triangle (NASDAQ:HCTI) shares declined by 15.21% to $0.77. The market value of their outstanding shares is at $1.8 million.
  • Bullfrog AI Hldgs (NASDAQ:BFRG) stock declined by 14.31% to $0.81. The company's market cap stands at $17.6 million.
  • Aclarion (NASDAQ:ACON) shares fell 14.18% to $2.52. The company's market cap stands at $8.4 million.
  • Viking Therapeutics (NASDAQ:VKTX) stock decreased by 12.25% to $36.55. The company's market cap stands at $4.8 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending